Prospects for the GSK and Novartis Consumer Health Joint Venture

In April 2014, GlaxoSmithKline Plc and Novartis AG announced plans to create a consumer health joint venture to be completed in the first half of 2015. Their extensive global presence and range of top-selling consumer health brands have the potential to establish the partnership as the new industry leader. Pending approvals, the joint venture will be a powerhouse in over-the-counter remedies and hold a commanding market share of analgesics, NRT smoking cessation aids, dermatologicals and more.